Exploration of Involved Key Genes and Signaling Diversity in Brain Tumors (Q39298204)

10 September 2017

1 reference

title

Exploration of Involved Key Genes and Signaling Diversity in Brain Tumors (English)

1 reference

10 September 2017

author name string

Mojdeh Mahdian Nasser

series ordinal

1

1 reference

10 September 2017

Parvin Mehdipour

series ordinal

2

1 reference

10 September 2017

publication date

10 May 2017

1 reference

Cellular and Molecular Neurobiology

10 September 2017

published in

1 reference

MYCC and MYCN oncogene amplification in medulloblastoma. A fluorescence in situ hybridization study on paraffin sections from the Children's Oncology Group

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

CHD5 is a tumor suppressor at human 1p36

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Analysis of the IDH1 codon 132 mutation in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

SUMO1 modification stabilizes CDK6 protein and drives the cell cycle and glioblastoma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Sonic hedgehog induces transcription-independent cytoskeletal rearrangement and migration regulated by arachidonate metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Expression and rearrangement of the ROS1 gene in human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

The p53 gene and its role in human brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

MDM2 is a central node in the p53 pathway: 12 years and counting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Purinergic signaling in glioma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

PKB binding proteins. Getting in on the Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Cooperation between the Hic1 and Ptch1 tumor suppressors in medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Purinergic signalling and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Telomerase activity and expression of telomerase reverse transcriptase correlated with cell proliferation in meningiomas and malignant brain tumors in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Role of receptor tyrosine kinases and their ligands in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Mechanisms of disease: the PI3K-Akt-PTEN signaling node--an intercept point for the control of angiogenesis in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Adenosine signaling in glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Malignant glioma: lessons from genomics, mouse models, and stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Vertebrate animal models of glioma: understanding the mechanisms and developing new therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Neurofibromatosis-1 regulation of neural stem cell proliferation and multilineage differentiation operates through distinct RAS effector pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Frequent loss of heterozygosity and altered expression of the candidate tumor suppressor gene 'FAT' in human astrocytic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Brain tumours: classification and genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Novel BRAF Alteration in a Sporadic Pilocytic Astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Extracellular purines, purinergic receptors and tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

CD95 maintains stem cell-like and non-classical EMT programs in primary human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

The genetics of pediatric brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Prognostic factors in infants and very young children with intracranial ependymomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Childhood medulloblastoma: novel approaches to the classification of a heterogeneous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

PTEN signaling in brain: neuropathology and tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Brain cancer stem cells display preferential sensitivity to Akt inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Telomerase expression in intracranial tumours: prognostic potential for malignant gliomas and meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Telomerase in brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Notch1 and notch2 have opposite effects on embryonal brain tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

PI3K/Akt: getting it right matters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

BRCA2 is required for neurogenesis and suppression of medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Radial glial identity is promoted by Notch1 signaling in the murine forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

The p53 pathway in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

PTEN Tumor Suppressor Network in PI3K-Akt Pathway Control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Controlling cytoplasmic c-Fos controls tumor growth in the peripheral and central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

21 January 2018

Genetics of adult glioma

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

IDH mutation and neuroglial developmental features define clinically distinct subclasses of lower grade diffuse astrocytic glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Defining the role of mTOR in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

An orally bioavailable c-Met kinase inhibitor potently inhibits brain tumor malignancy and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Glioma formation, cancer stem cells, and akt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Tumor suppressors: recessive mutations that lead to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Epidermal Growth Factor Receptor in Glioma: Signal Transduction, Neuropathology, Imaging, and Radioresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Copy number alterations of the polycomb gene BMI1 in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

CD73 is expressed by inflammatory Th17 cells in experimental autoimmune encephalomyelitis but does not limit differentiation or pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Length of telomeric repeats in neuroblastoma: correlation with prognosis and other biological characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Epigenetic inactivation of RASSF1A candidate tumor suppressor gene at 3p21.3 in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Targeting the Hedgehog Pathway in Pediatric Medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

APC mutations in sporadic medulloblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Overview of primary brain tumors: pathologic classification, epidemiology, molecular biology, and prognostic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Hedgehog--Gli signaling in brain tumors: stem cells and paradevelopmental programs in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

The Epithelial-to-Mesenchymal Transition-Like Process in Glioblastoma: An Updated Systematic Review and In Silico Investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

PI3K/PTEN signaling in tumorigenesis and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Constitutively active Rheb induces oncogenic transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Expression of cyclin D2, P53, Rb and ATM cell cycle genes in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Alterations of telomere length in human brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Telomerase activity in human brain tumors: astrocytoma and meningioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Identification of an amplified, highly expressed gene in a human glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Mutation analysis of the Ras pathway genes NRAS, HRAS, KRAS and BRAF in glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Genetic alteration and expression of the phosphoinositol-3-kinase/Akt pathway genes PIK3CA and PIKE in human glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Telomerase activity in human brain tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Telomerase reactivation in cancers: Mechanisms that govern transcriptional activation of the wild-type vs. mutant TERT promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

EphrinA5 acts as a tumor suppressor in glioma by negative regulation of epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

ATM gene mutations are not involved in medulloblastoma in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

The 2007 WHO classification of tumours of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Telomerase: central regulator of all of the hallmarks of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

The genetic and epigenetic basis of ependymoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

REST in good times and bad: roles in tumor suppressor and oncogenic activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

AKT/PKB signaling: navigating downstream

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Tumorigenic activity and therapeutic inhibition of Rheb GTPase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Pathological classification and molecular genetics of meningiomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Three-hit hypothesis in astrocytoma: tracing the polymorphism D1853N in ATM gene through a pedigree of the proband affected with primary brain tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Linking ATM Promoter Methylation to Cell Cycle Protein Expression in Brain Tumor Patients: Cellular Molecular Triangle Correlation in ATM Territory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Genome-wide analysis of alternative splicing in medulloblastoma identifies splicing patterns characteristic of normal cerebellar development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Loss of INI1 protein expression defines a subgroup of aggressive central nervous system primitive neuroectodermal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Diverse roles for the Eph family of receptor tyrosine kinases in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Notch1 functions as a tumor suppressor in mouse skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

TERT promoter mutations in primary and secondary glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Medulloblastomics: the end of the beginning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Genetic pathways to primary and secondary glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Genetic alterations and signaling pathways in the evolution of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Basal cell carcinomas in mice overexpressing sonic hedgehog

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Yes-Associated Protein 1 Is Widely Expressed in Human Brain Tumors and Promotes Glioblastoma Growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Molecular analysis of the TSC1 and TSC2 tumour suppressor genes in sporadic glial and glioneuronal tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Meningothelial hyperplasia: a detailed clinicopathologic, immunohistochemical and genetic study of 11 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

A coding-independent function of gene and pseudogene mRNAs regulates tumour biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

PTEN induces cell cycle arrest by decreasing the level and nuclear localization of cyclin D1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Gene expression profiling and genetic markers in glioblastoma survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

SV40 small T antigen and PP2A phosphatase in cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

CHEK2 mutations in primary glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Molecular changes during the genesis of human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

RAS pathway activation and an oncogenic RAS mutation in sporadic pilocytic astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Paradoxical activation and RAF inhibitor resistance of BRAF protein kinase fusions characterizing pediatric astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

CTNNB1, AXIN1 and APC expression analysis of different medulloblastoma variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Loss of ATM/Chk2/p53 pathway components accelerates tumor development and contributes to radiation resistance in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Next-generation molecular genetics of brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Myc proteins in brain tumor development and maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

LRP1B deletion is associated with poor outcome for glioblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Mutations in SUFU predispose to medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Targeting EGFR for treatment of glioblastoma: molecular basis to overcome resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Study of hTERT and Histone 3 Mutations in Medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Protean PTEN: form and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

The role of extracellular-5'-nucleotidase/CD73 in glioma peritumoural brain edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Genetics of brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Introduction of a normal human chromosome 11 into a Wilms' tumor cell line controls its tumorigenic expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

The cellular myb oncogene is amplified, rearranged and activated in human glioblastoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

No evidence for the H133Y mutation in SONIC HEDGEHOG in a collection of common tumour types

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Amplification of the structurally and functionally altered epidermal growth factor receptor gene (c-erbB) in human brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Role of Wnt pathway in medulloblastoma oncogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Alterations of BRAF and HIPK2 loci predominate in sporadic pilocytic astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Yes-associated protein (YAP) functions as a tumor suppressor in breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Hamartomatous polyposis syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Oncogenic EGFR signaling cooperates with loss of tumor suppressor gene functions in gliomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Analysis of PTCH/SMO/SHH pathway genes in medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-017-0498-9

Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line

21 January 2018

1 reference

12 December 2020

The analysis of malignancy by cell fusion: the position in 1988.

1 reference

12 December 2020

CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas.

1 reference

12 December 2020

Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas.

1 reference

12 December 2020

Amplified genes in human gliomas.

1 reference

12 December 2020

Epidemiology, cytogenetics, and molecular biology of brain tumors.

1 reference

12 December 2020

Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations.

1 reference

12 December 2020

Human glioblastomas with no alterations of the CDKN2A (p16INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene

1 reference

12 December 2020

Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets.

1 reference

12 December 2020

Cyclin-dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA.

1 reference

12 December 2020

Advances in the molecular genetics of gliomas

1 reference

12 December 2020

Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system

1 reference

12 December 2020

Telomerase activity and alterations in telomere length in human brain tumors

1 reference

12 December 2020

Expression patterns of Notch1, Notch2, and Notch3 suggest multiple functional roles for the Notch-DSL signaling system during brain development

1 reference

12 December 2020

Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma.

1 reference

12 December 2020

Tumor suppressor genes in breast cancer: the gatekeepers and the caretakers

1 reference

12 December 2020

Activation of Akt and Erk pathways in medulloblastoma

1 reference

12 December 2020

Genetic changes of CDH1, APC, and CTNNB1 found in human brain tumors.

1 reference

12 December 2020

Evolutionary hypothesis of telomere length in primary breast cancer and brain tumour patients: a tracer for genomic–tumour heterogeneity and instability

1 reference

12 December 2020

Molecular Pathways Mediating Metastases to the Brain via Epithelial-to-Mesenchymal Transition: Genes, Proteins, and Functional Analysis

1 reference

12 December 2020

10.1007/S10571-017-0498-9

Identifiers

DOI

1 reference

10 September 2017

1 reference